Lv1
50 积分 2024-12-12 加入
Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial
2天前
已完结
Elevated serum soluble interleukin-2 receptor levels in subacute cutaneous lupus erythematosus
9天前
已完结
Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus
9天前
已完结
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial
11天前
已完结
Systemic lupus erythematosus disease activity index 2000
12天前
已完结
New insights into the progression from cutaneous lupus to systemic lupus erythematosus
1个月前
已完结
Correlations between lichen planus and autoimmune diseases: a Mendelian randomization study
1个月前
已完结
Research advances in systemic lupus erythematosus in 2021
1个月前
已完结
SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX
1个月前
已完结
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus
2个月前
已完结
皖公网安备34019202002308
